Skip to main content
Journal of Cellular and Molecular Medicine logoLink to Journal of Cellular and Molecular Medicine
. 2023 Jun 16;27(12):1761–1762. doi: 10.1111/jcmm.17775

Corrigendum

PMCID: PMC10273067  PMID: 37325952

In Xue W et al., 1 Figures 2, 4 and 7 were incorrect due to an error in the preparation of these figures for publication. It was noticed that the image for CD56 and Perforin of YT F9 in Figure 2, were coming from photographs of YT F0. In addition, the images for TIA1 of NKYS F4 and F7 in Figure 4, the image for EBER of YT F5 in Figure 7, are the same with the left panel (images for CD56 of NKYS F4 and F7 in Figure 4, the image for EBER of YT F0 in Figure 7). The corrected figures appear below. The authors confirmed all results and conclusions of this article remain unchanged. We apologize for any confusion this may have caused.

FIGURE 2.

FIGURE 2

The tumour tissues in YT F0, YT F5, and YT F7 were positive for CD56, Granzyme B, Perforin.

FIGURE 4.

FIGURE 4

Immunohistochemical staining in NKYS models showed the large atypical cells were positive for CD56, Granzyme B, Perforin, TiA1.

FIGURE 7.

FIGURE 7

EBV was strongly detected in situ hybridization for EBV RNA using the EBER probe in YT and later passage tissues.

REFERENCE

  • 1. Xue W, Li W, Shang Y, et al. One method to establish Epstein‐Barr virus‐associated NK/T cell lymphoma mouse models. J Cell Mol Med. 2019;23(2):1509‐1516. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Cellular and Molecular Medicine are provided here courtesy of Blackwell Publishing

RESOURCES